Prevalence and Incidence of Neurofibromatosis
Neurofibromatosis: Rare Disease
Neurofibromatosis is listed as a "rare disease" by the Office of
Rare Diseases (ORD) of the National Institutes of Health
(NIH). This means that Neurofibromatosis, or a subtype of Neurofibromatosis,
affects less than 200,000 people in the US population.
Ophanet, who are a consortium of European partners,
currently defines a condition rare when if affects 1 person per 2,000.
They list Neurofibromatosis as a "rare disease".
More information about Neurofibromatosis is available from Orphanet
Neurofibromatosis Prevalence: Book Excerpts
Incidence (annual) of Neurofibromatosis:
about 1 in 30001. ... see also overview of Neurofibromatosis.
Incidence Rate:
approx 1 in 3,000 or 0.03% or 90,666 people in USA [Source statistic for calcuation: "about 1 in 30001." -- see also general information about data sources]
Incidence extrapolations for USA for Neurofibromatosis:
90,666 per year,
7,555 per month,
1,743 per week,
248 per day,
10 per hour,
0 per minute,
0 per second.
[Source statistic for calculation: "about 1 in 30001." -- see also general information about data sources]
Prevelance statistics for Neurofibromatosis:
The following statistics relate to the prevalence of Neurofibromatosis:
- 4,000 people world wide have neurofibromatosis Type 1 (British Colombia Neurofibromatosis Foundation)
- more statistics...»
Prevalence/Incidence of Neurofibromatosis: Online Medical Books
16 MEDICAL BOOKS ONLINE!
Review excerpts from medical books online, free, without registration,
for more information about the prevalence and/or incidence of Neurofibromatosis.
Neurofibromatosis:
Causes and incidence
(Professional Guide to Diseases (Eighth Edition))
NF-1 is an autosomal dominant disorder of chromosome 17 that occurs in about 1 in 3,000 births. Approximately 50% of affected families have a negative family history; in many of these families, the father is older, suggesting that advanced paternal age may influence the NF-1 mutation. NF-2 is an autosomal dominant disorder of chromosome 22; however, many patients have a negative family history.
» READ BOOK EXCERPT ONLINE »
Source: Professional Guide to Diseases (Eighth Edition), 2005
Neurofibromatosis:
Neurofibromatosis - epidemiology
(The 5-Minute Pediatric Consult)
Independent of sex, race, or environmental factors
Neurofibromatosis - incidence
1 in every 3,000–4,000 live births
Neurofibromatosis - prevalence
NF1 affects 100,000 Americans.
» READ BOOK EXCERPT ONLINE »
Source: The 5-Minute Pediatric Consult, 2008
About prevalence and incidence statistics:
The term 'prevalence' of Neurofibromatosis usually refers to the estimated population
of people who are managing Neurofibromatosis at any given time.
The term 'incidence' of Neurofibromatosis refers to the annual diagnosis rate,
or the number of new cases of Neurofibromatosis diagnosed each year.
Hence, these two statistics types can differ:
a short-lived disease like flu can have high annual incidence but low prevalence,
but a life-long disease like diabetes has a low annual incidence but high prevalence.
For more information see about prevalence and incidence statistics.
Whenever you go to a hospital or clinic for a major procedure or diagnostic test, one of the many forms you are given to sign is an "informed...
Sexual contact can sometimes result in problems. An unwanted pregnancy or sexually transmitted diseases may be some of those consequences. But by...
Stress takes its toll by making us anxious, depressed and not able to function as fully as we'd like. What many don't know is that stress can...
Health insurance is important to everyone, especially people with chronic conditions like Crohn's disease and ulcerative colitis. Tune in to...
See full list of 4 related videos
» Next page: Videos related to Neurofibromatosis
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards: